4//SEC Filing
FONTEYNE PAUL R. 4
Accession 0000899243-22-021890
CIK 0001658551other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:05 PM ET
Size
5.4 KB
Accession
0000899243-22-021890
Insider Transaction Report
Form 4
FONTEYNE PAUL R.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-09+19,000→ 19,000 totalExercise: $13.56Exp: 2032-06-09→ Common Stock (19,000 underlying)
Footnotes (1)
- [F1]This option shall vest in full upon the earlier of (i) June 9, 2023 or (ii) the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director.
Documents
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeother
Related Parties
1- filerCIK 0001727550
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 4:05 PM ET
- Size
- 5.4 KB